Have a personal or library account? Click to login
Biopharmaceutical aspects of the development of transdermal forms of Lisinopril dihydrate Cover

Biopharmaceutical aspects of the development of transdermal forms of Lisinopril dihydrate

Open Access
|Sep 2024

References

  1. International Society of Hypertension. World Hypertension Day; 2023. [https://ish-world.com/world-hypertension-day-2023/]
  2. Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organisation; 2021. [https://apps.who.int/iris/bitstream/handle/10665/344424/9789240033986-eng.pdf]
  3. Skolnik N. The new blood pressure targetin primary care. Medscape. 2023. [https://www.medscape.com/viewarticle/987184?form=fpf]
  4. Ahmad H, Khan H, Haque S, Ahmad S, Srivastava N, Khan A. Angiotensin – converting enzyme and hypertension: A systemic analysis of various ACE inhibitors, their side effects, and bioactive peptides as a putative therapy for hypertension. JRAAS. 2023;2023: 7890188.
  5. Bakris GL. Drugs for Hypertension. University of Chicago School of Medicine; 2022. [https://www.msdmanuals.com/professional/cardiovascular-disorders/hypertension/drugs-for-hypertension]
  6. Zheng W, Tian E, Liu Z, Zhou C, Yang P, Tian K, et al. Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective. Front Pharmacol. 2022;13:968104.
  7. Lizynopryl (Lisinopril). Kompendium. Likarski preparaty. [https://compendium.com.ua/uk/akt/76/3045/lisinoprilum/]
  8. Olvera LE, Parmar M, Pendela VS, Jamie MT. Lisinopril. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
  9. Dumitriu BO, Paduraru AM, Stefan CS, Dinu M, Cocos DI, Nwabudike LC, et al. Strategies for improving transdermal administration: New approaches to controlled drug release. Pharmaceutics. 2023;15:1183.
  10. Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trend sand applications. Drug Deliv Transl Res. 2022;12(4):758-91.
  11. Jitendra B, Pathaka AK, Subhash P. Development and optimisation of transdermal system of lisinopril dehydrate: Employing permeation enhancers. Iran J Pharm Sci. 2010;6(4).
  12. Rajendra M, Srinivas A. Formulation and characterisation transdermal patches for enhancing the bio-availability of lisinopril dihydrate. Int J Med Nanotechnol. 2015;2(6):306-10.
  13. Aparanjitha R, Sunitha RM, Sarangapani M. Formulation And In vitro evaluation of transferosomal patches for enhanced drug delivery of lisinopril dihydrate. J Scient Res. 2020;64(3):105-9.
  14. Lisinopril dihydrate. EuropeanPharmacopoeia. Strasbourg: EDQM; 2016: 2010-2.
DOI: https://doi.org/10.2478/cipms-2024-0027 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 166 - 170
Submitted on: Dec 23, 2023
|
Accepted on: May 6, 2024
|
Published on: Sep 7, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Tatyana Shyteyeva, Elena Bezchasnyuk, Oleg Kryskiv, Inna Baranova, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.